A trial of type 12 purinergic (P2Y12) receptor inhibition with prasugrel identifies a potentially distinct endotype of patients with aspirin-exacerbated respiratory disease
| Image |  |
|---|---|
| Description | scientific article published on 08 June 2018 |
| Author/s |
author: Juan Carlos Cardet |
| Publication date | June 8, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |